Cargando…

Identification of a small molecule inhibitor of Ebola virus genome replication and transcription using in silico screening

Ebola virus (EBOV) causes a severe haemorrhagic fever in humans and has a mortality rate over 50%. With no licensed drug treatments available, EBOV poses a significant threat. Investigations into possible therapeutics have been severely hampered by the classification of EBOV as a BSL4 pathogen. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Easton, Victoria, McPhillie, Martin, Garcia-Dorival, Isabel, Barr, John N., Edwards, Thomas A., Foster, Richard, Fishwick, Colin, Harris, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371959/ https://www.ncbi.nlm.nih.gov/pubmed/29870771 http://dx.doi.org/10.1016/j.antiviral.2018.06.003

Ejemplares similares

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design
por: Rawson, S., et al.
Publicado: (2017)

Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators
por: Turvey, Samuel J., et al.
Publicado: (2022)

An Investigation of the Effect of Transfected Defective, Ebola Virus Genomes on Ebola Replication
por: Smither, Sophie J., et al.
Publicado: (2020)

Quantification of Ebola virus replication kinetics in vitro
por: Liao, Laura E., et al.
Publicado: (2020)

Inhibiting the transcription and replication of Ebola viruses by disrupting the nucleoprotein and VP30 protein interaction with small molecules
por: Ma, Yan-hong, et al.
Publicado: (2023)

De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region
por: Orritt, Kyle M., et al.
Publicado: (2022)

In silico Selection of Amplification Targets for Rapid Polymorphism Screening in Ebola Virus Outbreaks
por: Wassenaar, Trudy M., et al.
Publicado: (2019)

Antiviral Screening of Multiple Compounds against Ebola Virus
por: Dowall, Stuart D., et al.
Publicado: (2016)

Qualitative study of Ebola screening at ports of entry to the UK
por: Kesten, Joanna May, et al.
Publicado: (2018)

Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
por: Rawson, Shaun, et al.
Publicado: (2018)

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
por: Dowall, Stuart D, et al.
Publicado: (2014)

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
por: Reynard, Olivier, et al.
Publicado: (2015)

Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015)

Finding small molecules for the ‘next Ebola’
por: Ekins, Sean, et al.
Publicado: (2015)

Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles
por: Yoon, Yi-Seul, et al.
Publicado: (2020)

In silico-based vaccine design against Ebola virus glycoprotein
por: Dash, Raju, et al.
Publicado: (2017)

Cathepsin B & L Are Not Required for Ebola Virus Replication
por: Marzi, Andrea, et al.
Publicado: (2012)

The Cellular Protein CAD is Recruited into Ebola Virus Inclusion Bodies by the Nucleoprotein NP to Facilitate Genome Replication and Transcription
por: Brandt, Janine, et al.
Publicado: (2020)

Small molecule targeting of transcription-replication conflict for selective chemotherapy
por: Gu, Long, et al.
Publicado: (2023)

Epoxide based inhibitors of the hepatitis C virus non-structural 2 autoprotease
por: Shaw, Joseph, et al.
Publicado: (2015)

In silico analysis suggests interaction between Ebola virus and the extracellular matrix
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach
por: Baikerikar, Shruti
Publicado: (2017)

Identification of a lead like inhibitor of the hepatitis C virus non-structural NS2 autoprotease
por: Shaw, Joseph, et al.
Publicado: (2015)

A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System
por: Wang, Zhongyi, et al.
Publicado: (2018)

Small molecules with antiviral activity against the Ebola virus
por: Litterman, Nadia, et al.
Publicado: (2015)

Novel Antiviral Molecules against Ebola Virus Infection
por: Collados Rodríguez, Mila, et al.
Publicado: (2023)

Divide et impera: An In Silico Screening Targeting HCMV ppUL44 Processivity Factor Homodimerization Identifies Small Molecules Inhibiting Viral Replication
por: Ghassabian, Hanieh, et al.
Publicado: (2021)

Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism
por: Seesuay, Watee, et al.
Publicado: (2018)

Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses
por: Lasala, Fátima, et al.
Publicado: (2021)

Novel Synthetic Polyamines Have Potent Antimalarial Activities in vitro and in vivo by Decreasing Intracellular Spermidine and Spermine Concentrations
por: El Bissati, Kamal, et al.
Publicado: (2019)

The First Small-Molecule Inhibitors of Members of the Ribonuclease E Family
por: Kime, Louise, et al.
Publicado: (2015)

First In Silico Screening of Insect Molecules for Identification of Novel Anti-Parasitic Compounds
por: Gallinger, Tom L., et al.
Publicado: (2022)

In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease
por: Veljkovic, Veljko, et al.
Publicado: (2015)

Erratum: The First Small-Molecule Inhibitors of Members of the Ribonuclease E Family
por: Kime, Louise, et al.
Publicado: (2015)

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer
por: Lin, Z. Ping, et al.
Publicado: (2021)

Host Transcriptional Response to Ebola Virus Infection
por: Speranza, Emily, et al.
Publicado: (2017)

Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors
por: Whitmer, Shannon L.M., et al.
Publicado: (2018)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
por: Zhu, Wenjun, et al.
Publicado: (2019)

In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis
por: Latham, Antony M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g41telob3s0qoa5kt2528fcuob